Get Your Own Businessabc AI Visibility ID
Boost AI visibility, credibility, and discoverability
10x Genomics is a biotechnology company that develops platforms for single-cell genomics, gene expression, and epigenomics.
10x Genomics is a biotechnology company that develops platforms for single-cell genomics, gene expression, and epigenomics. The 10x Genomics platform enables researchers to study the behaviour of cells at single-cell resolution, providing insights into complex biological systems.
The company's products include Chromium Systems, which enables the generation of high-resolution genetic data from single cells; Loupe Software, which facilitates the visualization and analysis of single-cell data; and Chromium Connect, which assists with the integration of data between different systems. 10x Genomics also provides various services such as single-cell sequencing and bioinformatics.
10x Genomics is a biotech company based in California that provides innovative solutions for genomic research. The company was founded in 2012 by Serge Saxonov and Ben Hindson, who had previously worked together at the biotech company Bio-Rad Laboratories.
The company's core technology is based on microfluidics and molecular barcoding, which allow researchers to study genetic information at a single-cell level. This technology has significant implications for understanding complex biological systems and developing new therapies for diseases such as cancer and autoimmune disorders.
Since its founding, 10x Genomics has rapidly grown and expanded its product offerings. In 2015, the company launched its first product, the Chromium Single Cell Controller, which enables high-throughput single-cell gene expression analysis. The company has since developed additional products, including the Visium Spatial Gene Expression Solution, which allows researchers to analyze gene expression in spatially defined tissue sections.
10x Genomics went public in 2019 and is listed on the Nasdaq stock exchange under the ticker symbol TXG. The company has received numerous awards and accolades for its technology and innovation, including being named to Forbes' list of America's Most Promising Companies in 2015.
At its core, 10x Genomics believes that the key to improving human health lies in better understanding the fundamental processes that underpin life. By developing tools that enable researchers to study the genome at unprecedented levels of resolution, the company aims to catalyze breakthrough discoveries in fields such as oncology, immunology, and neuroscience.
In pursuing its mission, 10x Genomics is committed to collaboration and partnership, working closely with leading researchers, institutions, and organizations across the life sciences and healthcare industries. The company is also dedicated to operating with a high degree of ethical and social responsibility, recognizing the potential impact of its work on society and the environment.
10x Genomics is a biotechnology company that specializes in developing genomic and cellular analysis tools to accelerate research in life sciences and healthcare. While the company does not have a stated set of core values, its mission and goals are rooted in a commitment to innovation, collaboration, and social responsibility.
As a public company, 10x Genomics does not have stated investment criteria for external investors. However, investors who are interested in investing in 10x Genomics can evaluate the company based on its financial performance, growth potential, and competitive landscape.
The company focused on developing innovative genomic and cellular analysis technologies, 10x Genomics' portfolio of products and services spans a broad range of applications and areas of research. Here are a few examples of the company's key offerings:
